Shenzhen Chipscreen Biosciences Coの収益YQ/Q

Shenzhen Chipscreen Biosciences Coの収益YQ/Qは何ですか。

Shenzhen Chipscreen Biosciences Co., Ltd.の収益YQ/Qは27.01%です。

収益YQ/Qの定義は何ですか。

四半期収益成長率、前年比は、前年同期の業績と比較して、売上高の増加率がパーセンテージとして表されています。

Quaterly revenue growth is the amount by which revenue exceeds the revenue in a previous quarter. It is beneficial to look at a company's quarterly financials to identify how the company is performing over time not just during the current period. The usage of year over year comparison is advantageous in removing seasonalities in reporting the quarterly revenue growth and observing longterm trends.

SSEのセクタHealth Careにおける収益YQ/Qの企業と比べるShenzhen Chipscreen Biosciences Co

Shenzhen Chipscreen Biosciences Coは何をしますか。

Shenzhen Chipscreen Biosciences Co., Ltd. engages in the research, development, and sale of original small molecule drugs. The company develops precursor compounds and original new drug product lines that are in various research phase of the specific global intellectual property protection in three areas, such as cancer, metabolic diseases, and autoimmune diseases. Shenzhen Chipscreen Biosciences Co., Ltd. was founded in 2001 and is based in Shenzhen, China.

Shenzhen Chipscreen Biosciences Coと類似の収益yq/q